{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,17]],"date-time":"2026-06-17T05:51:22Z","timestamp":1781675482202,"version":"3.54.5"},"reference-count":27,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2026,6,17]],"date-time":"2026-06-17T00:00:00Z","timestamp":1781654400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Oncol."],"abstract":"<jats:p>Lambert-Eaton myasthenic syndrome (LEMS) is a rare autoimmune disorder characterized by impaired acetylcholine release at the neuromuscular junction, leading to proximal muscle weakness, autonomic dysfunction, and diminished or absent tendon reflexes. Here, we present a rare case of a 73-year-old male smoker with small cell lung cancer (SCLC), whose initial manifestation was LEMS. Notably, the patient tested seronegative for anti-voltage-gated calcium channel (VGCC) antibodies but was seropositive for anti-SOX1 antibodies. The diagnosis of LEMS was supported by characteristic clinical symptoms and electromyography findings. Subsequent imaging (chest CT and PET-CT) identified a left upper lobe lung mass, which was pathologically confirmed as SCLC, clinically staged as T1cN3M0 (IIIB). Following standard antitumor therapy, the patient\u2019s muscle weakness markedly improved, and his overall survival has exceeded 36 months. This case underscores the critical importance of testing for anti-SOX1 antibodies and applying the DELTA-P score for malignancy screening in high-risk patients presenting with LEMS-like symptoms, even when seronegative for anti-VGCC antibodies.<\/jats:p>","DOI":"10.3389\/fonc.2026.1825530","type":"journal-article","created":{"date-parts":[[2026,6,17]],"date-time":"2026-06-17T04:51:42Z","timestamp":1781671902000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":0,"title":["Anti-VGCC negative and Anti-SOX1 positive Lambert-Eaton myasthenic syndrome as the initial presentation of small cell lung cancer: a case report"],"prefix":"10.3389","volume":"16","author":[{"given":"Yezhou","family":"Chen","sequence":"first","affiliation":[{"name":"Department of Graduate, Shandong First Medical University & Shandong Academy of Medical Sciences","place":["Jinan, Shandong, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jian","family":"Zhang","sequence":"additional","affiliation":[{"name":"Department of Oncology, Central Hospital Affiliated to Shandong First Medical University","place":["Jinan, Shandong, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qinglun","family":"Hou","sequence":"additional","affiliation":[{"name":"Department of Pathology, Pingyin County People\u2019s Hospital","place":["Jinan, Shandong, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hen","family":"Li","sequence":"additional","affiliation":[{"name":"Department of Neurology, Central Hospital Affiliated to Shandong First Medical University","place":["Jinan, Shandong, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jie","family":"Liu","sequence":"additional","affiliation":[{"name":"Department of Oncology, Central Hospital Affiliated to Shandong First Medical University","place":["Jinan, Shandong, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wenhui","family":"Shi","sequence":"additional","affiliation":[{"name":"Department of Graduate, Shandong First Medical University & Shandong Academy of Medical Sciences","place":["Jinan, Shandong, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Meili","family":"Sun","sequence":"additional","affiliation":[{"name":"Department of Oncology, Central Hospital Affiliated to Shandong First Medical University","place":["Jinan, Shandong, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2026,6,17]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","DOI":"10.1016\/j.disamonth.2025.101967","article-title":"The recognition, physiology, and treatment of Lambert-Eaton myasthenic syndrome","volume":"71","author":"Randall","year":"2025","journal-title":"Dis Mon"},{"key":"B2","doi-asserted-by":"publisher","DOI":"10.1007\/s40120-022-00354-8","article-title":"The European Lambert-Eaton Myasthenic Syndrome Registry: Long-term outcomes following symptomatic treatment","volume":"11","author":"Meisel","year":"2022","journal-title":"Neurol Ther"},{"key":"B3","doi-asserted-by":"publisher","DOI":"10.1136\/bmjno-2023-000426","article-title":"Dilated fixed pupils and respiratory failure: a rare clinical course of Lambert-Eaton myasthenic syndrome","volume":"5","author":"Ten Brinck","year":"2023","journal-title":"BMJ Neurol Open"},{"key":"B4","doi-asserted-by":"publisher","DOI":"10.1016\/bs.irn.2025.04.027","article-title":"Lambert Eaton myasthenic syndrome","volume":"182","author":"El-Wahsh","year":"2025","journal-title":"Int Rev Neurobiol"},{"key":"B5","doi-asserted-by":"publisher","DOI":"10.1212\/01.wnl.0000037485.56217.5f","article-title":"Seronegative Lambert-Eaton myasthenic syndrome: study of 110 Japanese patients","volume":"59","author":"Nakao","year":"2002","journal-title":"Neurology"},{"key":"B6","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.97.8.4198","article-title":"Serological identification of embryonic neural proteins as highly immunogenic tumor antigens in small cell lung cancer","volume":"97","author":"G\u00fcre","year":"2000","journal-title":"Proc Natl Acad Sci USA"},{"key":"B7","doi-asserted-by":"publisher","DOI":"10.1016\/b978-0-323-95702-1.00344-4","article-title":"Lambert-Eaton myasthenic syndrome","volume":"200","author":"Lipka","year":"2024","journal-title":"Handb Clin Neurol"},{"key":"B8","doi-asserted-by":"publisher","DOI":"10.4065\/mcp.2010.0099","article-title":"Paraneoplastic syndromes: an approach to diagnosis and treatment","volume":"85","author":"Pelosof","year":"2010","journal-title":"Mayo Clinic Proc"},{"key":"B9","doi-asserted-by":"publisher","DOI":"10.1016\/j.ncl.2018.01.008","article-title":"Lambert-Eaton myasthenic syndrome","volume":"36","author":"Kesner","year":"2018","journal-title":"Neurol Clin"},{"key":"B10","doi-asserted-by":"publisher","first-page":"27","DOI":"10.2147\/DNND.S192588","article-title":"Lambert-Eaton myasthenic syndrome: early diagnosis is key","volume":"9","author":"Ivanovski","year":"2019","journal-title":"Degenerative Neurological Neuromuscular Dis"},{"key":"B11","doi-asserted-by":"publisher","DOI":"10.1111\/1759-7714.13385","article-title":"Successful treatment of advanced lung adenocarcinoma complicated with Lambert\u2010Eaton myasthenic syndrome: a case report and literature review","volume":"11","author":"Wang","year":"2020","journal-title":"Thorac Cancer"},{"key":"B12","doi-asserted-by":"publisher","DOI":"10.1007\/s00415-017-8541-9","article-title":"Lambert-Eaton myasthenic syndrome (LEMS): a rare autoimmune presynaptic disorder often associated with cancer","volume":"264","author":"Schoser","year":"2017","journal-title":"J Neurol"},{"key":"B13","doi-asserted-by":"publisher","DOI":"10.1016\/j.jneuroim.2025.578681","article-title":"N-type voltage-gated calcium channel antibody testing lacks diagnostic value in Lambert-Eaton myasthenic syndrome","volume":"406","author":"Arlt","year":"2025","journal-title":"J Neuroimmunol"},{"key":"B14","doi-asserted-by":"publisher","DOI":"10.1016\/j.ncl.2018.01.008","article-title":"Electrophysiological differences in seropositive and seronegative Lambert-Eaton myasthenic syndrome","volume":"35","author":"Oh","year":"2007","journal-title":"Muscle Nerve"},{"key":"B15","doi-asserted-by":"publisher","DOI":"10.1016\/j.clinph.2014.06.031","article-title":"Lambert-Eaton myasthenic syndrome - diagnosis, pathogenesis and therapy","volume":"125","author":"Hulsbrink","year":"2014","journal-title":"Clin Neurophysiol"},{"key":"B16","doi-asserted-by":"publisher","DOI":"10.3988\/jcn.2020.16.4.530","article-title":"Anti-SOX1 antibodies in paraneoplastic neurological syndrome","volume":"16","author":"Sun","year":"2020","journal-title":"J Clin Neurol"},{"key":"B17","doi-asserted-by":"publisher","DOI":"10.1016\/b978-0-323-95702-1.00344-4","article-title":"SOX1 antibodies in Lambert-Eaton myasthenic syndrome and screening for small cell lung carcinoma","volume":"1275","author":"Lipka","year":"2012","journal-title":"Ann N Y Acad Sci"},{"key":"B18","doi-asserted-by":"publisher","DOI":"10.1111\/crj.13740","article-title":"SOX-1 antibodies positive Lambert-Eaton myasthenic syndrome with occult small cell lung cancer: a case report","volume":"18","author":"Zhao","year":"2024","journal-title":"Clin Respir J"},{"key":"B19","doi-asserted-by":"publisher","DOI":"10.2147\/ndt.s296714","article-title":"Myasthenia gravis and Lambert-Eaton myasthenic syndrome: new developments in diagnosis and treatment","volume":"18","author":"Pascuzzi","year":"2022","journal-title":"Neuropsychiatr Dis Treat"},{"key":"B20","doi-asserted-by":"publisher","DOI":"10.1016\/j.jns.2025.125700","article-title":"Serological testing patterns among individuals newly diagnosed with myasthenia gravis","volume":"480","author":"Pesa","year":"2026","journal-title":"J Neurol Sci"},{"key":"B21","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(21)00517-1","article-title":"Guillain-barr\u00e9 syndrome","volume":"397","author":"Shahrizaila","year":"2021","journal-title":"Lancet"},{"key":"B22","doi-asserted-by":"publisher","DOI":"10.1136\/bcr-2020-235668","article-title":"Paraneoplastic subacute sensory neuropathy with triple positive antineuronal antibodies associated with small-cell lung cancer","volume":"13","author":"Hean","year":"2020","journal-title":"BMJ Case Rep"},{"key":"B23","doi-asserted-by":"publisher","first-page":"10546","DOI":"10.1038\/s41598-020-67571-9","article-title":"Lung cancer prediction in Lambert-Eaton myasthenic syndrome in a prospective cohort","volume":"10","author":"Maddison","year":"2020","journal-title":"Sci Rep"},{"key":"B24","doi-asserted-by":"publisher","DOI":"10.1200\/jco.2010.32.0440","article-title":"Clinical Dutch-English Lambert-Eaton myasthenic syndrome (LEMS) tumor association prediction score accurately predicts small-cell lung cancer in the LEMS","volume":"29","author":"Titulaer","year":"2011","journal-title":"J Clin Oncol"},{"key":"B25","doi-asserted-by":"publisher","DOI":"10.1007\/978-3-540-29676-8_9280","article-title":"The association between Lambert-Eaton myasthenic syndrome and small cell lung carcinoma","volume":"2","author":"Briggs","year":"2013","journal-title":"Immunotargets Ther"},{"key":"B26","doi-asserted-by":"publisher","first-page":"3912376","DOI":"10.3816\/clc.2006.n.008","article-title":"Lambert-Eaton myasthenic syndrome in lung cancer","volume":"2022","author":"Wang","year":"2022","journal-title":"Contrast Media Mol Imaging"},{"key":"B27","doi-asserted-by":"publisher","DOI":"10.1001\/jama.2025.0560","article-title":"Small cell lung cancer: a review","volume":"333","author":"Kim","year":"2025","journal-title":"Jama"}],"container-title":["Frontiers in Oncology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fonc.2026.1825530\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,6,17]],"date-time":"2026-06-17T04:51:52Z","timestamp":1781671912000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fonc.2026.1825530\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,6,17]]},"references-count":27,"alternative-id":["10.3389\/fonc.2026.1825530"],"URL":"https:\/\/doi.org\/10.3389\/fonc.2026.1825530","relation":{},"ISSN":["2234-943X"],"issn-type":[{"value":"2234-943X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,6,17]]},"article-number":"1825530"}}